eratoconus is a corneal thinning disease that results in a focally reduced corneal radius of curvature, abnormal wavefront aberrations, and a localized reduction in corneal thickness and stiffness. These aberrations lead to a decline in visual function that ultimately may require corneal transplantation.
O R I G I N A L A R T I C L E
eratoconus is a corneal thinning disease that results in a focally reduced corneal radius of curvature, abnormal wavefront aberrations, and a localized reduction in corneal thickness and stiffness. These aberrations lead to a decline in visual function that ultimately may require corneal transplantation. 1 Corneal cross-linking (CXL) with riboflavin and ultraviolet-A (UVA) is an established treatment for progressive keratoconus and currently is the only therapeutic approach that is capable of significantly altering disease progression. 2 Available for many years in Europe, this treatment option has been recently approved by the U.S. Food and Drug Administration for use in the United States. 2 The so-called "Dresden" or "standard" protocol is the current standard approach for CXL for keratoconus and consists of 30 minutes' exposure to 3 mW fluence (5.4 mJ/cm 2 ) following 30 minutes of soaking in 0.1% riboflavin. 3 The Dresden protocol involves removal of the corneal epithelium followed by dosing of the corneal stroma with K ABSTRACT PURPOSE: To determine the relationship between mechanical behavior in cross-linked corneas and changes in the corneal ultrastructure after corneal cross-linking (CXL).
METHODS:
Porcine corneas were treated following the "Dresden" protocol, the current gold standard for clinical treatment, consisting of dropwise application of 0.1% riboflavin in 20% dextran followed by 30 minutes of ultraviolet-A (UVA) irradiation. The effect of CXL was assessed using uniaxial tensile testing, transmission electron microscopy, and Fourier transform infrared spectroscopy, with results compared against corneas treated with each of the treatment solution components individually.
RESULTS: UVA/riboflavin cross-linked corneas displayed 28% ± 17% increase in the material tangent modulus compared with dextran treatment alone, and altered collagen architecture within the first 300 µm of stromal depth consisting of 5% increase in the thickness of collagen fibrils, no significant changes to interfibrillar spacing, and an 8% to 12% decrease in number of fibrils per unit area. Fourier transform infrared spectroscopy confirmed formation of interfibrillar bonds (P = .012) induced by UVA-mediated CXL.
CONCLUSIONS:
The data support a model wherein collagen fibril diameter and structural density are fundamental parameters in defining tissue stiffening following UVA/riboflavin CXL and provide benchmarks against which modifications to the Dresden CXL protocol can be evaluated.
[J Refract Surg. 2018;34(4): 264-272.] Mechanical Behavior and Corneal Ultrastructure After CXL/Chang et al 0.1% riboflavin in 20% dextran for 30 minutes, then exposure to ultraviolet light over a 30-minute period. The rationale behind this approach is that photo-polymerization, in the presence of the photosensitizer riboflavin, leads to creation of chemical bonds between substrates within the corneal stroma, including between collagens and proteoglycans and other stromal proteins. [3] [4] [5] The effects of these induced cross-links have been variously reported as increases in tissue stiffness, resistance to enzymatic digestion, changes to ultrastructure, and altered swelling behavior. [6] [7] [8] [9] However, these studies have generally evaluated the overall effects of the full CXL protocol without separating the contribution of individual aspects of the treatment and there are some differences in outcomes reported. 5, 6, 10, 11 Mechanical properties of biological tissues are largely dependent on the intertwining of collagen fibrils, linked lamina layers, and interfibrillar spacing. [12] [13] [14] Therefore, the efficacy of the Dresden CXL protocol is believed to be dependent on changes to the mechanical properties of the tissue induced through modifying the characteristics of collagen fibrils within the cornea and the induction of intrafibrillar bonds, with the overall level of effect being dependent on treatment depth. 15, 16 Previous studies have attempted to evaluate mechanical properties and the effective CXL penetration depth by specifically examining anterior and posterior corneal layers. 9, 17, 18 These studies demonstrated that the CXL effect is predominantly located within anterior stroma but did not specify the parameters that may be involved in determining and defining the amount of the tissue stiffening induced. Indeed, the relationship between the mechanical behavior of the cross-linked cornea and its ultrastructure is poorly explored, and the specific contribution of the dextran within the riboflavin solution has not been reported. 18, 19 Numerous modifications to the Dresden protocol are being tested in clinical settings; therefore, defined knowledge of the effect of the current treatment regimen is needed to provide a benchmark against which these modifications can be compared and moreover for rationale design of alternative approaches. The current study aimed to improve this understanding by systematically investigating the role of dextran and the effect of UVA/riboflavin CXL in inducing mechanical and ultrastructural changes in the porcine cornea.
MATERIALS AND METHODS

CXL ProCedure and eXPerimentaL design
Fresh porcine eyes were collected from an abattoir, washed with phosphate-buffered saline (PBS) (Sigma, Dorset, United Kingdom), the central corneas excised, and the corneal epithelium removed. To control for inter-animal variation, each cornea was cut into two segments in a superior-inferior fashion, with one being used as the test sample and the other for the control treatment (Figure A , available in the online version of this article).
There were four groups. The PBS vs PBS group (control) contained 6 corneas and each half cornea was topically treated with PBS in 3-minute intervals for 1 hour and used to examine the intrinsic differences between the two segments of each porcine cornea. The PBS vs riboflavin+PBS group contained 6 corneas and each corneal segment was topically treated in 3-minute intervals for 1 hour with either PBS or 0.1% riboflavin (Sigma) prepared in PBS. The PBS vs riboflavin+dextran group contained 6 corneas and treatment was the same as for the PBS vs riboflavin+PBS group, except that the riboflavin was prepared in 20% dextran (Sigma). The dextran vs riboflavin+dextran+UVA group contained 10 corneas and half were treated following the conventional Dresden protocol, 3 with the anterior surface of the corneas treated with 5 mL of 0.1% riboflavin in 20% dextran at 3-minute intervals for 30 minutes, followed by UVA (370 nm) illumination at 3 mW/cm 2 (Opto Xlink; Mehra Eyetech Pvt. Ltd., Delhi, India) for a further 30 minutes. Topical dosing of riboflavin with dextran drops was continued every 3 minutes during the UVA irradiation (for full CXL details following the standard convention, see Table 1 ). 20 CXL corneas were compared to fellow segments treated with 20% dextran only.
Following treatment, the corneal tissues were dissected for mechanical testing and for ultrastructural analysis (Figure A) .
tensiLe testing
Corneal stiffness was examined using a uniaxial tensile tester (Instron 3366; Instron Engineering Corporation, Norwood, MA), equipped with a 10N load cell. Two strips (3 mm width × 6 mm length) cut in the superior-inferior direction at the central cornea were inserted vertically into custom-designed clamps and the protocol set to apply a maximum loading stress of 0.125 MPa, slightly above the stress expected under an intraocular pressure of 80 mm Hg. 21 A constant extension of 1 mm/min was applied and the corresponding stress (applied force divided by cross-sectional area) and strain (extension over original length) measured continuously. Five conditioning cycles, 21 with 4-minute recovery periods between two cycles, were performed. The tangent modulus (Et), the gradient of a tangent of the stress-strain behavior pattern, was calculated at different stress levels to derive the overall stiffness of the tissue. 22, 23 transmission eLeCtron miCrosCoPy (tem) TEM was performed as described previously. 6 Briefly, the specimens were isolated from the central regions of cornea ( Figure A ) and fixed overnight with 2.5% glutaraldehyde (TAAB Laboratories Equipment Ltd., Reading, United Kingdom) in 0.1% tannic acid. Thereafter, specimens were dissected into 1 × 2 mm blocks and incubated with 4% osmium (TAAB), followed by serial dehydration through an acetone gradient (30%, 50%, 70%, 90%, and 100%) (Sigma). Specimens were then infiltrated and embedded in medium resin (TAAB) and ultrathin 70-nm thickness sections cut using a diamond knife microtome and collected onto 200 mesh copper grids (Ted Pella, Inc., Reading, CA). Sections were examined using a Tecnai G2 spirit BioTWIN Transmission electron microscope (FEI Company, Hillsboro, OR) operated at 120 kV and 60 k-fold magnification with a charge coupled device camera. Tissues were sampled at five depth intervals from the top of the anterior stroma: 0 to 50, 80 to 150, 200 to 250, 300 to 350, and 400 to 450 µm. Collagen fibrils in longitudinal, frontal, and oblique profiles were observed in TEM images; only those in frontal profiles were used for quantitative analysis with analyses performed using Fiji software (National Institutes of Health, Bethesda, MD). Ultrastructural parameters evaluated were: mean diameter of collagen fibrils, interfibrillar spacing, and number of fibrils per unit area. For mean diameter of collagen fibrils, circular spots in frontal profiles were isolated and exported and diameters measured. The calculation of interfibrillar spacing was generated from Equation 1 while assuming that the collagen fibrils were evenly distributed:
Here R was defined as interfibrillar spacing (nm), D as mean diameter of collagen fibrils (nm), A as the area of selected zone of measurement (nm 2 ), and N as the number of fibrils (circular spots) within the selected zone. The number of fibrils per unit area was determined by randomly localizing a window of fixed unit size (300 × 300 nm) and the number of circular spots counted.
The distribution curve of collagen fibrils was assessed with a bespoke code using MATLAB 2016b software (The MathWorks, Inc., Natick, MA). Original images were converted to binary using adaptive thresholding and a custom-designed collagen fibril detection system, using the Circular Hough Transform-based algorithm, 24, 25 was established to analyze the radius of circular objects in frontal profiles of TEM images. Distribution curves were generated by plotting the frequency in 2-nm increments against fibril radius.
Fourier transForm inFrared (Ftir) absorPtion sPeCtrosCoPy
Fresh porcine corneas were treated with either PBS, 0.1% riboflavin in 20% dextran, or the full Dresden protocol (6 per group), lyophilized for 3 days, then measured with FTIR spectroscopy using a Nicolet 6700 FTIR spectrometer (Thermo Fisher Scientific, Chelmsford, MA) with an attenuated total reflection module. Sixty-four accumulative scans were taken with a resolution of 4 cm -1 between 800 and 4,000 cm -1 . Data were collected using OMNIC software (Thermo Fisher Scientific). Analyses of FTIR spectra of each condition were obtained with a combination of four spectral intervals . Area under the curve at each interval was analyzed using KnowItAll ID Expert software (Bio-Rad, Hercules, CA).
statistiCaL anaLysis
Results for mechanical, ultrastructural, and FTIR spectra analyses are presented as mean ± standard deviation and statistical significance calculated using one-way analysis of variance with Turkey's HSD posthoc tests. The Mann-Whitney U test (two-tailed) was used for analyzing the statistical difference of the dis- RESULTS UVA/riboflavin treatment and dextran-mediated dehydration both contribute to mechanical property changes in CXL. To isolate the effect of the individual components of UVA/riboflavin CXL, uniaxial tensile experiments and TEM were conducted on a set of porcine eyes split into paired comparison groups. To account for inter-animal variability, each cornea was cut in two and half treated with the treatment and compared against the control (Figure A) (tensile measurements and ultrastructural analyses were performed on the same cornea). Comparison groups were: PBS vs PBS, riboflavin+PBS vs PBS, riboflavin+dextran vs PBS and riboflavin+dextran+UVA vs dextran (Figure A) .
The tangent modulus (Et) versus stress (s) for each corneal strip was determined and the overall stiffening effect indicated by the ratio of the tangent modulus (Et experimental / Et control ). Comparisons concentrated on tangent modulus ratios at a stress of 0.03 MPa, which is equivalent to a physiological intraocular pressure of approximately 25 mm Hg. 21 As expected, no significant differences were observed where both corneal segments were treated identically with PBS, confirming the validity of our intra-eye control system (Et experimental PBS vs Et control PBS : 1.36 ± 0.32 vs 1.43 ± 0.30 at 0.03 MPa, respectively, P = .075, Figures BA-BB, and Table A, available in the online version of this article). Riboflavin in PBS treatment also caused no stiffening (riboflavin in PBS: 1.45 ± 0.15 vs PBS: 1.38 ± 0.17, P = .448, Figure BC, Table A) . However, the riboflavin+dextran group displayed a 13% ± 9% tangent modulus increase compared to their internal PBS control (riboflavin in dextran: 1.52 ± 0.17 vs PBS: 1.34 ± 0.18, P = .011, Figure BD, Table A) . Comparing the effect of the full Dresden CXL protocol to the effect of dextran treatment alone, we observed a 28% ± 17% increase in tangent modulus in the corneal segments treated by the Dresden protocol (riboflavin+dextran+UVA: 2.09 ± 0.17 vs dextran: 1.62 ± 0.18, P < .001, Figure BE, Table A ).
The differences observed with dextran alone were somewhat surprising, but on comparing the tissue thicknesses following treatments, we observed statistically significant reduced thicknesses in the dextran-treated samples compared with their PBS controls that were indicative of dehydration (mean thickness riboflavin in dextran: 0.79 ± 0.04 mm, PBS: 1.05 ± 0.39 mm, P = 1.39 × 10 -6 ) ( Figure BF, Table A) . Correcting the tangent modulus readings with these thickness measurements removed the apparent dextran effects, whereas a residual stiffening effect was still observed in the samples treated with the Dresden protocol after correction (Figure BG) .
Together, these data demonstrate that dextran treatment alone causes dehydration and therefore an apparently increased stiffening, whereas corneas treated with UVA/riboflavin exhibit further increased stiffening beyond that caused by the dextran treatment alone.
uVa/riboFLaVin treatment Causes dePth-dePendent Changes to CoLLagen FibriL uLtrastruCture Next, we measured changes to the collagen ultrastructure of specimens, measured at five different depth intervals using TEM (Figure C , available in the online version of this article, and Figure BA ; representative images at 80 to 150 mm) and the obtained images were used to determine collagen fibril diameter (Figure BB) , interfibrillar spacing, and fibril number per unit area (density) ( Table  B , available in the online version of this article). The overall morphologies of the collagen ultrastructure did not change following PBS or riboflavin in PBS treatment in the absence of UVA ( Figure C, Table B) . However, the dextran treatment led to significantly thinner collagen fibrils (Figure 1A) , as well as reduced interfibrillar spacing and denser packing at all depth intervals compared to its PBS control (Figure C) . Because dextran also causes loss of tissue hydration, we used a mathematical method to correct for dehydration effects to identify the true structural changes. 26 The relationship between thickness (T) and hydration (H) was modelled using the equation: T = 0.2*e^(0.33*H), which has been shown to be effective for these types of calculation. 26 The reduction in thickness followed an exponential decrease in tissue hydration, which we used to calculate the hydration state of the tissues and therefore calculate swelling factors at each depth interval (Table C, available in the online version of this article). Analysis of fibril diameter at each depth interval revealed that although dextran treatment caused a reduction in the frequency of large collagen fibrils compared to PBS treatment (Figure 1B ; 80 to 150 mm, Tables B-C) in the uncorrected data, when correction for swelling factors was included, no significant differences were detected ( Figure 1B, Figure D , available in the online version of this article), indicating that dextran treatment alone has no effect on collagen fibril diameter.
In analyzing the effect of the Dresden UVA/riboflavin CXL protocol on corneal ultrastructure, both segments within our intra-eye comparisons were treated with dextran. Therefore, any residual difference between the internal controlled comparison groups reflected a true effect of the CXL procedure. Analysis revealed a small but statistically significant increase in collagen fibril diameter in the CXL group at 80 to 150 µm (5% ± 2%, P < .01) and 200 to 250 µm depths (6% ± 3%, P < .01), with no differences observed at any other depth intervals (Figures 2C-2D, Figure D) . No statistical differences in interfibrillar spacing between treatments were observed at any depths (Figure 2E ), but the Dresden protocol caused a decrease in the number of fibrils per unit area in the anterior 250 µm of the tissue (0 to 50 µm: 6% ± 5%, P < .05; 80 to 150 µm: 11% ± 7%, P < .01; 200 to 250 µm: 11% ± 5%, P < .01) (Figure 3, Table B ). Together, these data indicate that the UVA/riboflavin CXL procedure creates relatively small, depth-localized changes to the collagen ultrastructure.
indiViduaL uLtrastruCturaL measurements are insuFFiCient to PrediCt meChaniCaL Changes
Because we had performed the tangent modulus and ultrastructural measurements on the same eye (Figure A) , we were able to directly compare the values obtained (Figure 3) . Comparisons were made between mechanical outcomes measured at 0.03 MPa stress and structural parameters were determined from tissues in relaxed states. Collagen fibril diameter at 80 to 150 µm, intrafibril spacing increases, and collagen fibril density decreases each displayed correlation with tangent modulus increases across the test population (diameter: r 2 =0.23, Figure 3A ; spacing: r 2 = 0.39, Figure 3B ; density: r 2 = 0.52, Figure 3C ). When percentage change on an individual eye basis was plotted, none of the individual ultrastructural parameters were independently indicative of the overall tissue stiffness (Figure 3D) . However, when considered in combination, the ultrastructural measurements performed better, with a positive correlation of 0.177 (collagen fibril diameter + fibril density -interfibrillar spacing, Figure 3E ). ) were used as an internal standard to determine the intensity ratios (Figure 4C, Table D , available in the online version of this article). These analyses revealed significant increases in the C-O stretch peak, decreased C-N stretch, and increased NH 2 deformation following CXL (Figure 4C) . Plotting the ratio of C-N stretch to NH 2 deformation suggests that the decrease intensities of amide II infrared absorption bands are likely to be accompanied by an increase in the formation of amide III bonds (riboflavin+dextran+UVA = 2.5 ± 0.5; PBS = 1.7 ± 0.3; riboflavin+dextran = 1.8 ± 0.2; Figure 4D , Table D) .
DISCUSSION
In this study, we have characterized how corneal mechanical properties relate to ultrastructural changes following the Dresden protocol treatment and identified the contribution of the different components of the protocol to observed effects. Specifically, our data demonstrate that the increases in corneal stiffness measured following Dresden protocol treatment arise from a combination of dextran-mediated dehydration and UVA/riboflavin-induced new bond formation and depth-dependent increases in collagen fibril diameter.
Tissue stiffness is considered a combination of the internal geometry of the tissue and the properties of the material itself. Therefore, although our data indicate that almost half of the measured stiffening effect of the Dresden protocol as measured ex vivo comes from the dextran component of the protocol, these effects can be explained by dehydration effects. How- Mechanical Behavior and Corneal Ultrastructure After CXL/Chang et al ever, we did observe an increase in C-O stretching force in the riboflavin in the dextran-treated corneas compared with controls, indicating that dextran does itself induce collagen changes. A potential explanation for these new bonds is that the dextran-induced dehydration increases the swelling pressure of tissue and therefore the resistance pressure of proteoglycan matrix, 26, 27 giving rise to intermolecular forces. These dextran and dehydration effects could help explain some of the apparently contradictory reports in the literature. 5, 6, 10, 11 Interestingly, tissue hydration states have been reported to affect the efficacy of CXL treatment 27 ; therefore, hydration states and the osmolarity of the riboflavin solutions could be important factors to consider in protocol modifications.
Our FTIR data revealed significant changes in C-O stretching force and conversion rate of amide bonds following the full Dresden protocol. Lysine-based cross-links following UVA/riboflavin CXL have previously been postulated but not been found chemically, 3, 28 and it has been proposed that cross-links form through endogenous carbonyl groups including imidazole formation. 29 Our data support a model where the increased swelling pressure and the involvement of endogenous carbonyls (allysine) leads to the new bond formation. 22 This leads to a broader mechanism where UVA/riboflavin-induced intrafibril bonds present as thickened collagen fibrils and less dense overall structure and drive the increased tissue mechanical strength and resistance to dehydration (Figure E , available in the online version of this article).
However, it should be noted that the ultrastructural changes we measured do not fully account for the mechanical effects, suggesting that collagen fibril diameter and spacing are not the only aspects of stromal biology affected by UVA/riboflavin CXL. Effects on other stromal proteins and particularly the interactions of collagen with proteoglycans could be contributing to the stiffening. Proteoglycans within the corneal stroma have been proposed to play a pivotal role in regulating the fibril-fibril spacing and hydration-dehydration properties, 30 but the dehydration-induced decrease in interfibril spacing has prevented us from being able to determine the sole effect of CXL on proteoglycans within our experimental system.
Understanding the stabilization mechanism of UVA/ riboflavin CXL is clinically relevant when evaluating modifications to the Dresden protocol and developing optimal protocols or new keratoconus treatments. This study establishes the standards in terms of mechanical, chemical, and structure/biological changes induced by the Dresden protocol and therefore provides the baseline against which modifications can be judged.
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Figure A. Experimental scheme. Each cornea was cut into two segments in a superior-inferior fashion. The right-hand segment was used as an experimental segment, whereas the left-hand segment was used as its corresponding control. After each treatment, specimens were dissected and processed for tensile testing (green hollow rectangle) and transmission electron microscopy (TEM) (red hollow rectangle). S = superior; I = inferior; PBS = phosphate-buffered saline; UVA = ultraviolet-A 
